Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.26.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Noncontrolling Interest [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2024 $ 1 $ 23,750 $ 325 $ (17,996) $ 6,080
Balance, shares at Dec. 31, 2024 381,925        
Net income (loss) 34 (712) (678)
Share-based compensation and restricted stock issuances 166 166
Share-based compensation and restricted stock issuances, shares 777        
Balance at Mar. 31, 2025 $ 1 23,916 359 (18,708) 5,568
Balance, shares at Mar. 31, 2025 382,702        
Balance at Dec. 31, 2024 $ 1 23,750 325 (17,996) 6,080
Balance, shares at Dec. 31, 2024 381,925        
Net income (loss)         (1,965)
Balance at Sep. 30, 2025 $ 1 25,211 390 (20,026) 5,576
Balance, shares at Sep. 30, 2025 407,138        
Balance at Mar. 31, 2025 $ 1 23,916 359 (18,708) 5,568
Balance, shares at Mar. 31, 2025 382,702        
Net income (loss) 25 (665) (640)
Share-based compensation and restricted stock issuances 127 127
Share-based compensation and restricted stock issuances, shares 25        
Balance at Jun. 30, 2025 $ 1 24,043 384 (19,373) 5,055
Balance, shares at Jun. 30, 2025 382,727        
Net income (loss) 6 (653) (647)
Share-based compensation and restricted stock issuances 205 205
Share-based compensation and restricted stock issuances, shares 1,476        
Equity offering proceeds, net of stock issuance costs 963     963
Equity offering proceeds, net of stock issuance costs, shares 22,935        
Balance at Sep. 30, 2025 $ 1 25,211 390 (20,026) 5,576
Balance, shares at Sep. 30, 2025 407,138        
Balance at Dec. 31, 2025 $ 1 25,454 432 (20,996) 4,891
Balance, shares at Dec. 31, 2025 407,157        
Restricted stock issuances 143 143
Restricted stock issuances, shares 1,016        
Issuance of securities for the conversion of convertible notes payable and accrued interest 319 319
Issuance of securities for the conversion of convertible notes payable and accrued interest, shares 15,612        
Net income (loss) 56 (927) (871)
Balance at Mar. 31, 2026 $ 1 25,916 488 (21,923) 4,482
Balance, shares at Mar. 31, 2026 423,785        
Balance at Dec. 31, 2025 $ 1 25,454 432 (20,996) $ 4,891
Balance, shares at Dec. 31, 2025 407,157        
Restricted stock issuances, shares         3,413
Net income (loss)         $ (5,572)
Share-based compensation and restricted stock issuances, shares         44,493
Balance at Sep. 30, 2026 $ 1 30,797 536 (26,670) $ 4,664
Balance, shares at Sep. 30, 2026 487,383        
Balance at Mar. 31, 2026 $ 1 25,916 488 (21,923) 4,482
Balance, shares at Mar. 31, 2026 423,785        
Issuance of securities for the conversion of convertible notes payable and accrued interest 613 613
Issuance of securities for the conversion of convertible notes payable and accrued interest, shares 61,216        
Net income (loss) 29 (3,635) (3,606)
Stock-based compensation - stock options/restricted 119 119
Warrants issued in conjunction with the conversion of convertible notes payable 3,858 3,858
Balance at Jun. 30, 2026 $ 1 30,506 517 (25,558) 5,466
Balance, shares at Jun. 30, 2026 485,001        
Issuance of securities for the conversion of convertible notes payable and accrued interest 24 24
Issuance of securities for the conversion of convertible notes payable and accrued interest, shares 2,382        
Net income (loss) 19 (1,112) (1,093)
Stock-based compensation - stock options/restricted 14 14
Warrants issued in conjunction with the conversion of convertible notes payable 253 253
Balance at Sep. 30, 2026 $ 1 $ 30,797 $ 536 $ (26,670) $ 4,664
Balance, shares at Sep. 30, 2026 487,383